Black Americans Lagging Behind Other Races for COVID-19 Vaccination as the More Infectious Delta Variant Spreads Across US By Brian Good July 7, 2021
153 Texas Hospital Employees Fired or Resign Over Refusal To Get COVID-19 Vaccine By Brian Good June 23, 2021
White House Announces ‘National Month of Action’ To Promote COVID-19 Vaccinations; Partners With Black-Owned Barbershops To Reach Minority Communities By Brian Good June 3, 2021
Vaccination Gap Widens for Black and Latinx Individuals, But Not Necessarily Because of Vaccine Hesitancy By Brian Good April 28, 2021
California, Massachusetts, Louisiana and North Carolina Have Vaccinated the Largest Portions of Their Black Populations Against COVID-19 By Brian Good March 19, 2021
President Biden Promises All Americans Will be Eligible for COVID-19 Vaccine by May 1; Sets July 4th for Tentative Celebration of ‘Independence’ from the Virus By Brian Good March 12, 2021
California Commits To Distributing 40% of Its Existing Vaccine Doses To Underserved Communities By Brian Good March 5, 2021
Ex-Michigan Governor Charged for Racist Lead Poisoning of Flint Water Supply; COVID-19 Vaccines Not Increasing in Availability; Democrats Plan to Repeal Trump Rules; and More By Brian Good January 15, 2021
The US Breaks Its Record for Daily COVID-19 Deaths — Again; New Hope in Reuniting Immigrant Families Separated by Trump Administration at the Border; and More By Brian Good December 4, 2020
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine By Featured Partner August 3, 2020
As COVID-19 Vaccine Trials Commence, Diversity Becomes a Vital Issue By DiversityInc Staff July 27, 2020
Sanofi and GSK to Join Forces in Unprecedented Vaccine Collaboration to Fight COVID-19 By Featured Partner April 14, 2020
Johnson & Johnson Announces ‘Road to a Vaccine’ Live Series to Document Fight Against COVID-19 By Featured Partner April 13, 2020
Johnson & Johnson Working to Develop Potential Vaccine for COVID-19 By Featured Partner March 1, 2020
Sanofi: FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older By Featured Partner November 4, 2019
